Kim YJ - Search Results

1

Impact of Low Skeletal Muscle Mass on Long-Term Outcomes in Hepatocellular Carcinoma Treated with Trans-Arterial Radioembolization: A Retrospective Multi-Center Study.

Nam H, Yang H, Chun HS, Lee HA, Nam JY, Jang JW, Seo YS, Kim DY, Kim YJ, Bae SH. Nam H, et al. Among authors: kim yj, kim dy. Cancers (Basel). 2023 Oct 28;15(21):5195. doi: 10.3390/cancers15215195. Cancers (Basel). 2023. PMID: 37958368 Free PMC article.

2

Clinical features of autoimmune hepatitis and comparison of two diagnostic criteria in Korea: a nationwide, multicenter study.

Kim BH, Kim YJ, Jeong SH, Tak WY, Ahn SH, Lee YJ, Jung EU, Lee JI, Yeon JE, Hwang JS, Um SH, Seo YS, Kim YS, Song BC, Kim JH, Jung YK, Park CK, Kim KA, Min HJ, Cho EY, Lee ES, Kwon SY, Chae HB, Kim DJ, Shin SR. Kim BH, et al. Among authors: kim yj, kim ka, kim dj, kim ys, kim jh. J Gastroenterol Hepatol. 2013 Jan;28(1):128-34. doi: 10.1111/j.1440-1746.2012.07292.x. J Gastroenterol Hepatol. 2013. PMID: 23033899

3

Clinical outcomes of transjugular intrahepatic portosystemic shunt for portal hypertension: Korean multicenter real-practice data.

Kim HK, Kim YJ, Chung WJ, Kim SS, Shim JJ, Choi MS, Kim DY, Jun DW, Um SH, Park SJ, Woo HY, Jung YK, Baik SK, Kim MY, Park SY, Lee JM, Kim YS. Kim HK, et al. Among authors: kim ss, kim yj, kim dy, kim ys, kim my. Clin Mol Hepatol. 2014 Mar;20(1):18-27. doi: 10.3350/cmh.2014.20.1.18. Epub 2014 Mar 26. Clin Mol Hepatol. 2014. PMID: 24757655 Free PMC article.

4

Radioembolization Is a Safe and Effective Treatment for Hepatocellular Carcinoma with Portal Vein Thrombosis: A Propensity Score Analysis.

Cho YY, Lee M, Kim HC, Chung JW, Kim YH, Gwak GY, Bae SH, Kim do Y, Heo J, Kim YJ. Cho YY, et al. Among authors: kim yh, kim yj, kim do y, kim hc. PLoS One. 2016 May 5;11(5):e0154986. doi: 10.1371/journal.pone.0154986. eCollection 2016. PLoS One. 2016. PMID: 27149067 Free PMC article.

5

Synergistic effect of cytokine-induced killer cell with valproate inhibits growth of hepatocellular carcinoma cell in a mouse model.

Lee DH, Nam JY, Chang Y, Cho H, Kang SH, Cho YY, Cho E, Lee JH, Yu SJ, Kim YJ, Yoon JH. Lee DH, et al. Among authors: kim yj. Cancer Biol Ther. 2017 Jan 2;18(1):67-75. doi: 10.1080/15384047.2016.1276132. Cancer Biol Ther. 2017. PMID: 28055304 Free PMC article.

6

Oral Medications Enhance Adherence to Surveillance for Hepatocellular Carcinoma and Survival in Chronic Hepatitis B Patients.

Nam JY, Lee JH, Kim HY, Kim JE, Lee DH, Chang Y, Cho H, Yoo JJ, Lee M, Cho YY, Cho Y, Cho E, Yu SJ, Kim YJ, Yoon JH. Nam JY, et al. Among authors: kim hy, kim yj, kim je. PLoS One. 2017 Jan 18;12(1):e0166188. doi: 10.1371/journal.pone.0166188. eCollection 2017. PLoS One. 2017. PMID: 28099520 Free PMC article.

7

3-bromopyruvate and buthionine sulfoximine effectively kill anoikis-resistant hepatocellular carcinoma cells.

Lee M, Jo A, Lee S, Kim JB, Chang Y, Nam JY, Cho H, Cho YY, Cho EJ, Lee JH, Yu SJ, Yoon JH, Kim YJ. Lee M, et al. Among authors: kim yj, kim jb. PLoS One. 2017 Mar 31;12(3):e0174271. doi: 10.1371/journal.pone.0174271. eCollection 2017. PLoS One. 2017. PMID: 28362858 Free PMC article.

8

Sub-classification of Advanced-Stage Hepatocellular Carcinoma: A Cohort Study Including 612 Patients Treated with Sorafenib.

Yoo JJ, Chung GE, Lee JH, Nam JY, Chang Y, Lee JM, Lee DH, Kim HY, Cho EJ, Yu SJ, Kim YJ, Yoon JH; Seoul Liver Group. Yoo JJ, et al. Among authors: kim hy, kim yj. Cancer Res Treat. 2018 Apr;50(2):366-373. doi: 10.4143/crt.2017.126. Epub 2017 May 15. Cancer Res Treat. 2018. PMID: 28521494 Free PMC article.

9

Antiplatelet therapy and the risk of hepatocellular carcinoma in chronic hepatitis B patients on antiviral treatment.

Lee M, Chung GE, Lee JH, Oh S, Nam JY, Chang Y, Cho H, Ahn H, Cho YY, Yoo JJ, Cho Y, Lee DH, Cho EJ, Yu SJ, Lee DH, Lee JM, Kim YJ, Yoon JH. Lee M, et al. Among authors: kim yj. Hepatology. 2017 Nov;66(5):1556-1569. doi: 10.1002/hep.29318. Epub 2017 Sep 29. Hepatology. 2017. PMID: 28617992

10

Adjuvant immunotherapy with autologous dendritic cells for hepatocellular carcinoma, randomized phase II study.

Lee JH, Tak WY, Lee Y, Heo MK, Song JS, Kim HY, Park SY, Bae SH, Lee JH, Heo J, Kim KH, Bae YS, Kim YJ. Lee JH, et al. Among authors: kim hy, kim yj, kim kh. Oncoimmunology. 2017 May 16;6(7):e1328335. doi: 10.1080/2162402X.2017.1328335. eCollection 2017. Oncoimmunology. 2017. PMID: 28811965 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13,091 results

Search Page

Filters